It would require FDA approval and CLIA waiver to be used in these settings. That could realistically take years.
We have the first mover advantage here.
im in the same boat as you with at1, in since the ipo.
I think Febridx is going to save at1, without it we were dead in the water.
I really like pascal, nothing else like it on the market, and now that it’s waived we should have other companies knocking on our door to use it.
On another note, I wonder if AT1 could collaborate with LDX
and their distribution deal with phase to bring their hiv test to the US market?
It would require FDA approval and CLIA waiver to be used in...
Add to My Watchlist
What is My Watchlist?
